1 – 10 of 43
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Apixaban vs rivaroxaban in patients with atrial fibrillation at high or low bleeding risk : A population-based cohort study
2024) In Heart Rhythm(
- Contribution to journal › Article
- 2023
-
Mark
Prophylaxis use of clotting factor replacement products in people with non-severe haemophilia : A review of the literature
(
- Contribution to journal › Scientific review
-
Mark
Clinical, economic, and health-related quality of life burden associated with von Willebrand disease in adults and children : Systematic and targeted literature reviews
(
- Contribution to journal › Scientific review
-
Mark
Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference
(
- Contribution to journal › Article
- 2022
-
Mark
Pretreatment with heparin in patients with ST-segment elevation myocardial infarction : a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
(
- Contribution to journal › Article
-
Mark
Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS-IPS study
(
- Contribution to journal › Article
- 2021
-
Mark
Validation of the 4-item PRECISE-DAPT score : A SWEDEHEART study
(
- Contribution to journal › Article
-
Mark
Genetic Screening in Patients Suspected of Inherited Bleeding Disorders
2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Myocardial infarction - Risk stratification and evaluation of therapies
2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (monograph)
- 2020
-
Mark
Von Willebrand factor alloantibodies in type 3 von Willebrand disease
(
- Contribution to journal › Article